Phytomenadione 1mg/0.5mL Injection

Phytomenadione 1mg/0.5mL is vitamin K1 injection used to prevent or treat bleeding related to vitamin K deficiency or impaired vitamin K activity. The 1mg presentation is used in some neonatal protocols, with the route and dose selected for the individual clinical situation.
A clinician gives phytomenadione by intramuscular, slow intravenous or subcutaneous injection. The route and amount depend on whether treatment is newborn prophylaxis or correction of vitamin K-related bleeding. Protect the preparation from light; it is not for self-injection.
Vitamin K1 enables the liver to produce functional clotting factors II, VII, IX and X. Restoring these factors improves clotting when vitamin K deficiency or antagonism is responsible.
Pain, swelling or tenderness at the injection site can occur. Severe hypersensitivity, including anaphylaxis, has occurred with parenteral vitamin K, particularly intravenous or intramuscular emulsion administration.
Tell the treating team about anticoagulants, liver disease and previous injection reactions. Injectable vitamin K formulations differ in their permitted routes and excipients. Severe active bleeding requires emergency treatment because vitamin K alone does not act immediately.
Helps restore clotting-factor activity when vitamin K availability is the limiting cause of abnormal coagulation.
No. New clotting factors take time to be produced. Severe bleeding may also require clotting-factor replacement and other emergency measures.
No. It reverses vitamin K antagonism, such as warfarin's effect, but is not a general antidote for heparin or direct oral anticoagulants.
No. Birth weight, gestational age, route and local protocol matter. A 1mg ampoule should not be treated as a universal neonatal dose.
No. It supplies a vitamin needed for clotting and does not immunise against an infection.
These tests help establish whether deficient clotting-factor activity has corrected and whether further treatment is needed.
Not necessarily. Severe liver disease or a different bleeding disorder may explain the abnormal clotting. The cause needs reassessment.
No. Formulations and absorption differ, and route-specific dosing is important. A clinician must choose the preparation and regimen.
Their anticoagulation plan needs follow-up because warfarin responsiveness can be reduced for a period after reversal. Do not restart or increase warfarin independently.
Vitamin K1: phytomenadione, also called phytonadione. Clotting factor: a protein involved in blood coagulation. INR: a standardised measure used to monitor certain clotting abnormalities and warfarin. Neonatal prophylaxis: prevention of disease in a newborn.; AR: Phytomenadione 1mg/0.5mL حقن; FR: Phytomenadione 1mg/0.5mL injection; PT: Phytomenadione 1mg/0.5mL injeção; ES: Phytomenadione 1mg/0.5mL inyección; RU: Phytomenadione 1mg/0.5mL инъекция; ID: Phytomenadione 1mg/0.5mL injeksi; VI: Phytomenadione 1mg/0.5mL thuốc tiêm; MS: Phytomenadione 1mg/0.5mL suntikan; TL: Phytomenadione 1mg/0.5mL iniksyon; ZH-SG: Phytomenadione 1mg/0.5mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Phytomenadione 1mg/0.5mL Injection under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Phytomenadione 1mg/0.5mL Injection